Does serum ferritin correlate with coronary angiography findings?

International Journal of Cardiology

Volumn 69, Issue 2, 1999, Pages 149-153

  Manfroi, Waldomiro Carlos ^a   Zago, Alcides José ^a   Caramori, Paulo R A ^a   Cruz, Rosana ^a   Oliveira, Juliana ^a   Kirschnick, Luciana Schmidt ^a   Ordovás, Karen ^a   Candiago, Rafael Henriques ^a   De Souza, Josiane ^a   Ribeiro, Letícia Weiss ^a   Leitão, Cristiane ^a   Brizolara, Maria Luiza ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Atherosclerosis; Coronary artery disease; Ferritin; Risk factors Coronary angiography

Indexed keywords

CHOLESTEROL; FERRITIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

ANALYSIS OF VARIANCE; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; FERRITINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033562810     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00020-0     Document Type: Article

References (43)

1. Abbot RD, McGee D. The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. In: Kannel WB, Wolf PA, Garrison RI, editors, The Framingham Study: an Epidemiological Investigation of Cardiovascular Disease. Publication Nih, US Department of Health, Education, and Welfare, Washington, DC, 1987, pp. 87-2284.
2. Martin MJ, Browner WS, Hulley SB. Serum cholesterol, blood pressure and mortality: implications from a cohort of 361 622 men. Lancet 1986;2:933-6.
3. Stamler J, Wentworth D, Neaton ID. Is relationship between serum cholesterol and risk of premature death for coronary heart disease continuous and graded? J Am Med Assoc 1986;256:2823-8.
4. The Canadian Consensus Conference on Cholesterol. Final report. Canadian Medical Association Journal 1988; 139 (Suppl 1): 1-8.
5. Philips NR, Waters D, Havel RJ. Plasma lipoprotein and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993;88:2762-70.
6. Ross R. The pathogenesis of atherosclerosis - an update. New England Journal of Medicine 1986;314:488-500.
7. Segrest JP, Anantharamaiah GM. Pathogenesis of atherosclerosis. Current Opinion Cardiol 1994;9:404-10.
8. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol 1990;3:77-92.
9. Chisolm GM. Cytotoxicity of oxidized lipoproteins. Current Opinion in Lipidology 1991;2:311-6.
10. Carpenter KLH, Brabbs CE, Mitchinson MJ. Oxygen radicals and atherosclerosis. Klinische Wochenschrift 1991;69:1039-45.
11. Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. British Medical Bulletin 1993;49:566-76.
12. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. New Engl J Med 1989;320:915-23.
13. McCord IM. Is iron sufficiency a risk factor in ischemic heart disease? Circulation 1991;83:1112-4.
14. Cross CE, Halliwell B, Borish ET, Pryor WA, Saul RL, McCord JM, Harman D. Oxygen radicals and human disease. Annals of Internal Medicine 1987;107:526-45.
15. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: An overview. In: Packer L, Glazer AN, editors, Methods in Enzymology, Vol. 186, Academic Press, San Diego, 1989, pp. 1-85.
16. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4.
17. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. Journal of Clinical Investigation 1984;74:1890-4.
18. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177-88.
19. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and the risk of cardiovascular disease. The Framingham Study. Annals of Internal Medicine 1976;85:447-52.
20. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. New Engl J Med 1987;316:1105-10.
21. Sullivan JL. Sex, iron, and heart disease. Lancet 1986;2:1162.
22. Robinson RW, Higano N, Cohen WD. Increased incidence of coronary heart disease in women castrated prior to menopause. Archives of Internal Medicine 1959;104:908-13.
23. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease: The Framingham Study. Ann Int Med 1978;89:157-61.
24. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. New England Journal of Medicine 1994;330:1119-24.
25. Salonen JT, Nyyssonen K, Salonen R. Body iron stores and the risk of coronary heart disease. New Engl J Med 1994;331:1159-60.
26. National Institute of Health Consensus Development Conference Statement - National Institute of Health Consensus Development Panel on the Health Implications of Obesity Annals of Internal Medicine 1985;103 (Suppl 2):1073-1077.
27. Methods for Voluntary Weight Loss and Control. Proceedings of NIH Technology Assessment Conference. Ann Intern Med 1993; 119 (7 Pt 2):641-770.
28. Sones FJ, Sinrey EK. Coronary arteriography. Modern Concepts of Cardiovascular Disease 1962;31:735-8.
29. Judkins MF. Selective coronary arteriography: a percutaneous transfemoral technique. Radiology 1967;89:815-24.
30. Balla G, Jacob HS, Eaton JW, Belcher ID, Vercellotti GM. Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioslerosis and Thrombosis 1991;11:1700-11.
31. Carlin G, Djursater R. Xanthine oxidase induced depolymerization of hyaluronic acid in the presence of ferritin. FEBS Letters 1984;177:27-30.
32. Cozzi A, Santambrogio P, Levi S, Arosio P. Iron detoxifying activity of ferritin: Effects of H and L apoferritins on lipid peroxidation in vitro. FEBS Lett 1990;277:119-22.
33. Aruoma OI, Bomford A, Polson RJ, Halliwell B. Nontransferrinbound iron in plasma from hemochromatosis patients: Effect of phlebotomy therapy. Blood 1988;72:1416-9.
34. Cook JD, Lipschitz DA, Miles LE, Finch CA. Serum ferritin as a measure of iron store in normal subjects. Am J Clin Nutr 1974;27:681-7.
35. Cook JD, Skikne BS, Lynch SZ, Reusser ME. Estimates of iron sufficiency in the US population. Blood 1986;3:727-31.
36. Lauffer RB. Iron stores and the international variation in mortality from coronary artery disease. Medical Hypotheses 1991;35:96-102.
37. Morrison HI, Semenciw RM, Mao Y, Wigle DT. Serum iron and the risk of fatal acute myocardial infarction. Epidemiology 1994;5:243-6.
38. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1982;86:803-11.
39. Salonen JT, Nyyssönen K, Korpela H, Toumilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excessive risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
40. Kiechl S, Aichner F, Gerstenbrand F, Egger G, Mair A, Rungger G, Spogler F, Jarosch E, Oberhollenzer F, Willeit J. Body iron stores and presence of carotid atherosclerosis. Arterioscler Thromb 1994;14:1625-30.
41. Aronow WS. Serum ferritin is not a risk factor for coronary artery disease in men and women aged >62 years. Am J Cardiol 1993;72:347-8.
42. Magnusson MK, Sigfusson N, Sigvaddason H, Johannesson GM, Magnusson S, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102-8.
43. Kaltwasser JP, Werner E. Diagnosis and clinical evaluation of iron overload. Baillieres Clinical Haematology 1989;2:363-85.